PMA device
Collastat Absorbable Collagen Hemostatic Agents
Integra LifeSciences Corporation · Agent, Absorbable Hemostatic, Collagen Based (LMF, Class III) · First FDA decision Sep 20, 2006, newest Mar 26, 2009Surgical bleeding and hemostasis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
607
Naming "Collastat"
MAUDE reports
0
Brand "Collastat", since 2015
PubMed studies
11
Mentioning "Collastat"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Collastat Absorbable Collagen Hemostatic Agents
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTSPMA supplement
P810006-S032 · Decided Mar 26, 2009 · 52 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
- COLLASTAT ABSORBABLE COLLAGEN HEMOSTATIC AGENTSPMA supplement
P810006-S022 · Decided Sep 20, 2006 · 355 days after receipt · Normal 180 Day Track No User Fee
Device type: Agent, absorbable hemostatic, collagen based (LMF) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Collastat", any status and sponsor, newest update first.
- Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®Not yet recruiting
University of California, IrvineAcademic, hospital or other
NCT07821112 · 20 participants (planned) · Start Dec 2026 · Primary completion Oct 2027
Device: GammaTile® · For: Glioma; Glioblastoma; GBM and 5 more
Sites: Orange, California
- Study of Collagen-Based Thrombin Hemostat for the Control of Bleeding in Spinal SurgeryPivotal-lookingCompleted
DALIM TISSEN Co., Ltd.Not on our public-company list
NCT07354178 · 130 participants · Start Oct 22, 2024 · Primary completion Jun 19, 2025
Device: CollaStat®; Floseal® · For: Spinal Tumor; Spinal Injury; Hemostasis and 3 more
Sites: Seoul, South Korea; Yongin-si, South Korea · 3 sites in all
- A Prospective, Multicenter, Controlled Clinical Study of Collagen Fibrous Scaffold for the Treatment of Cesarean Scar DiverticulumNot yet recruiting
Women's Hospital School Of Medicine Zhejiang UniversityAcademic, hospital or other
NCT07930689 · 82 participants (planned) · Start Nov 6, 2026 · Primary completion Nov 30, 2029
Device: collagen fibrous scaffold · For: Cesarean Scar Diverticulum; Abnormal Vaginal Bleeding; Fertility Impairment
Sites: Hangzhou, China
604 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Collastat", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LMF
1,445 reports: 207 malfunction, 1,171 injury, 61 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Collastat"[tiab]. The summary above synthesizes these.
- Evaluation of a Novel Collagen Hemostatic Matrix: Comparison of Two Hemostatic Matrices in a Rabbits Jejunal Artery Injury Model.
Kim MJ, Kim JH, Kim JS, et al. · J Surg Res · 2019Comparative Study, Evaluation Study
- Efficacy and Safety of a Thrombin-Containing Collagen-Based Hemostatic Agent in Spinal Surgery: A Randomized Clinical Trial.
Park SM, Kang DR, Lee JH, et al. · World Neurosurg · 2021Randomized Controlled Trial
- Evaluation of hemostatic agents in experimental splenic lacerations.
Coln D, Horton J, Ogden ME, et al. · Am J Surg · 1983Comparative Study
- A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen.
DeLustro F, Condell RA, Nguyen MA, et al. · J Biomed Mater Res · 1986Comparative Study
- Collagen sponge as a topical hemostatic agent in mucogingival surgery.
Stein MD, Salkin LM, Freedman AL, et al. · J Periodontol · 1985
- Evaluation of a new hemostatic agent in experimental splenic laceration.
Horton JW, Garcia NM, Stone KR · Arch Surg · 1995Comparative Study
- Pigskin as a topical hemostat in arterial, liver, and splenic injuries.
Peper WA, Allor DR, Peterson EL, et al. · Surgery · 1986Comparative Study
- Effect of absorbable topical hemostatic agents on the relaxation time of blood: an in vitro study with implications for postoperative magnetic resonance imaging.
Spiller M, Tenner MS, Couldwell WT · J Neurosurg · 2001Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- Autogenous skin and fascia grafts as topical hemostatic agents in splenic injuries.
Eitan A, Munichor M, Barzilai A · Eur Surg Res · 1989
- Hemostatic efficacy of a flowable collagen-thrombin matrix during coronary artery bypass grafting: a double-blind randomized controlled trial.
Kim HH, Lee KJ, Kang DR, et al. · J Cardiothorac Surg · 2023Randomized Controlled Trial
- Clearance of pneumococcal organisms after repair of injured spleens.
Coln D, Horton J, Ogden M, et al. · J Pediatr Surg · 1983
Other devices of this type
Also filed under product code LMF.
- SURGIFOAM® Absorbable Gelatin SpongeFerrosan Meidcal Devices A/S · PMA 2026
- Floseal Hemostatic MatrixBaxter Healthcare Corp · PMA 2015
- Vitagel Surgical HemostatStryker Corp. · PMA 2013
- SURGIFLO Hemostatic Matrix Kit with ThrombinFerrosan Meidcal Devices A/S · PMA 2025
- Helistat Absorbable Collagen Hemostatic Sponge/OraFOAM Absorbable Collagen Hemostatic SpongeIntegra LifeSciences Corporation · PMA 2019
- Instat Collagen Absorbable HemostatETHICON, Inc. · PMA 2007
- Avitene Flowable Collagen HemostatDavol Inc., Sub. C. R. Bard, Inc. · PMA 2025
- Floseal (R) Matrix Hemostatic Sealant and Proceed (Tm) Hemostatic SealantBaxter Healthcare Corp · PMA 2001
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.